Congress gave NIH $47.2 billion, rejecting the White House's proposed 40% cut

The Consolidated Appropriations Act, 2026, signed into law 3 February, funds the National Institutes of Health at $47.2 billion for the fiscal year — $415 million, or 0.9%, above 2025's $46.8 billion, and a rejection of the White House's earlier proposal to cut NIH's budget by roughly $18 billion and restructure its 27 institutes and centers into eight [s1].

What the administration had proposed, and what didn't survive

The President's FY2026 budget request had proposed cutting NIH's roughly $48 billion 2025 appropriation by about 40%, to $27.5 billion, while consolidating its 27 institutes and centers into eight [s1]. Congress's final bill does neither: it maintains all 27 institutes and centers as separate entities and funds the agency above, not below, its prior-year level [s1]. The gap between a proposed 40% cut and an enacted 0.9% increase represents one of the widest distances between an administration's opening budget position and Congress's final appropriation for any single agency this cycle.

What else the law locks in

The Advanced Research Projects Agency for Health (ARPA-H), NIH's newer initiative modeled on the Pentagon's DARPA, is funded at $1.5 billion — flat against 2025, and a rejection of the administration's proposed cut of more than $500 million to that program specifically [s1]. The law also includes statutory language blocking the administration from imposing a 15% cap on facilities-and-administrative (F&A) cost reimbursement — the overhead payments universities and research institutions receive alongside direct grant funding, which the administration had separately sought to cap [s1].

Why this outcome happened, and what it doesn't mean

A budget proposal reflects an administration's opening position, not a guaranteed outcome — Congress holds the actual appropriations power, and a wide gap between a president's request and the final enacted number is a routine feature of the budget process, not evidence of an unusual fight. What made this particular gap notable is its size: a proposed near-halving of the agency's budget and a proposed dissolution of its institute structure, both of which Congress declined entirely rather than partially. Bipartisan appropriators, not a partisan majority alone, released the underlying minibus package, which is part of why NIH's funding came through intact where deeper cuts had been sought.

None of this means NIH's funding situation is resolved for future years — this law covers FY2026 specifically. A 0.9% increase is also roughly in line with or below general inflation, meaning NIH's real purchasing power for research grants may be flat or slightly down even as its nominal topline number rose.

What to watch next

Whether the administration's FY2027 budget request repeats a similar restructuring and cut proposal, and whether Congress's bipartisan appropriators hold the same line a second time — this year's outcome doesn't set a binding precedent for the next budget cycle, and NIH's institute structure and funding level will be back up for negotiation when that request arrives.